Conference Description

June 25, 2005
The Westin City Center Dallas
650 N. Pearl Street
Dallas, Texas 75201
214-979-9000

Tell a friend about this conference
Download the brochure for this conference.
See how attendees evaluated this conference

CME Credits 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this CME activity, the participant will be able to:

1. Utilize data from the latest randomized trials of statins to promote atherosclerotic regression and decrease cardiovascular disease
2. More effectively manage heart failure and understand indications and implications of biventricular devices and cardiac defibrillators
3. Utilize the latest data to effectively treat patients with GERD and erosive esophagitis as well as those requiring the regular use of NSAIDS
4. Evaluate, stage and manage patients with chronic kidney disease
5. Diagnose anemia of chronic kidney disease and understand the implications of its treatment
6. Distinguish Depression and Anxiety from Bipolar Disorder, and utilize effective treatments available
7. Recognize when to start insulin therapy and identify ideal candidates for pre-mix or basal-bolus insulin strategies, utilizing effective algorithms for achieving glycemic control
8. More effectively assess the severity disease in patients with COPD and formulate an effective therapeutic approach based on physiology of disease and the patient’s quality of life

Agenda:

7:30-8:10		Continental Breakfast and Registration
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:10		Atherosclerosis and Cardiovascular Disease: Factors Influencing Progression and Regression Charles H. Hennekens, MD
9:10-10:00		Integrating Advanced Heart Failure Management with the Use of Cardiac Devices: Role of the Primary Physician Juan Aranda, MD
10:00-10:20		Break/Vendor Area
10:20-11:10		Chronic Renal Disease Robert Toto, MD
11:10-12:00		Anemia in Chronic Kidney Disease: Past, Present and Future Robert Toto, MD
12:00-1:00		Lunch
1:00-1:10		Conference Update Gregg Sherman, MD
1:10-2:00		Advancing Insulin Therapy in Type 2 Diabetes: Practical Tools and Effective Algorithms Luigi Meneghini, MD
2:00-2:50		Differential Diagnosis and Treatment of Biopolar Disorder Trisha Suppes, MD, PhD
2:50-3:10		Break/Vendor Area
3:10-4:00		Acid Supression 2005: GERD to NSAIDS Kenneth R. DeVault, MD
4:00–4:50		COPD – A New Look at an Old Disease Bruce Krieger, MD
4:50-5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Juan Aranda, MD
Associate Professor of Medicine
Division of Cardiovascular Medicine
University of Florida College of Medicine, Gainesville, Florida

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
Jacksonville, Florida

Charles H. Hennekens, MD
Voluntary Professor of Medicine & Epidemiology and
Public Health, University of Miami School of Medicine (UMSM)
Research Professor of Biomedical Science
Center of Excellence, Florida Atlantic University (FAU),
Boca Raton, Florida

Bruce Krieger, MD
Professor of Medicine (voluntary)
Miller School of Medicine
University of Miami.

Luigi Meneghini, MD, MBA
Associate Professor of Clinical Medicine, University of Miami
Associate Director for Clinical Affairs of
the Diabetes Research Institute.
Co-Director of the State of Florida’s Southeastern Florida
Regional Diabetes Program

Trisha Suppes, MD, PhD
Associate Professor of Psychiatry
Director of Bipolar Disorders Research Program
UT Southwestern Medical Center Dallas

Robert D. Toto, M.D.
Professor of Medicine
Director, Patient Oriented Research
and Clinical Nephrology
UT Southwestern Medical Center Dallas
Dallas, Texas

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.0 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Amgen, Amylin, AstraZeneca, Boehringer Ingelheim, Merck, Novartis, Novo Nordisk, Takeda.